glutathione rapta c Tumor-targeted oxidation catalysis with ruthenium nanoreactors against hypoxic osteosarcoma Altered DNA Binding and Amplification
Altered DNA Binding and Amplification of Human Breast Cancer Suppressor Gene BRCA1 Induced by a Novel Antitumor Compound, [Ru(6 p phenylethacrynate)Cl2(pta)] Dichloro Ru(II) p cymene 1,3,5 triaza 7 phosphaadamantane (RAPTA C): A Case Study ACS Pharmacology & Translational Science The development of anticancer ruthenium(II) complexes: from single molecule compounds to nanomaterials PMC Synthesis, characterizacion and study of novel heterobimetallic RAPTA type Ru(II) complexes ScienceDirect
Pay in 4 interest-free payments of $6.49 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9



